XML 92 R62.htm IDEA: XBRL DOCUMENT v3.19.3
Earnings Per Share (Details)
3 Months Ended 9 Months Ended
Sep. 24, 2018
shares
Sep. 19, 2018
shares
Sep. 30, 2019
shares
Sep. 30, 2019
shares
Dec. 31, 2017
shares
Subsidiary, Sale of Stock [Line Items]          
Stock split ratio   2,932,900      
Weighted average number of shares issued basic (in shares)     7,300,000 7,300,000  
Antidilutive shares not included in calculating diluted earnings per share (in shares)     100,000 100,000  
IPO          
Subsidiary, Sale of Stock [Line Items]          
Number of shares issued (in shares) 72,300,000 72,335,000      
Elanco | Lilly          
Subsidiary, Sale of Stock [Line Items]          
Common shares outstanding   100     293,290,000